Poland· PL-100484968
Veinofytil
A hippocastani semen product containing hippocastani seminis extractum siccum, registered in Poland by Tilman S.A.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hippocastani semen is registered in 7 of 19 countries.
Countries holding a registration under ATC C05CX03 (hippocastani semen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Hippocastani semen · ATC C05CX03
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Hippocastani seminis extractum siccum
- Manufacturer
- Tilman S.A.
- Country
- Poland (PL)
- ATC code
- C05CX03
- ATC class
- Hippocastani semen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991537876
- gtin05909991537883
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hippocastani semen in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAesculus (White Chestnut)Bestmade Natural Products
- BelgiumAesculus Hippocastanum Boiron 200KBoiron
- NetherlandsA. Vogel Aesculaforce tablettenA.Vogel B.V.
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- FinlandAESCULUS Alfaplex (Al 12)
- FranceELUSANES MARRONNIER D'INDE, gélulePIERRE FABRE MEDICAMENT
- SpainCASTAÑO DE INDIAS ARKOPHARMA cápsulas durasArkopharma Laboratorios S.A.U.
- GermanyVenen-AktivPharma Aldenhoven Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Venen-Aktiv
- Italy · Flebostasin R
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f74eec59-4b14-43c6-b46b-dc659ef9c2d6 GET /v1/drugs/f74eec59-4b14-43c6-b46b-dc659ef9c2d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki dojelitowe",
"source": "urpl",
"strength": "21 mg glikozydów triterpenowych w przeliczeniu na protoescygeninę",
"packaging": "05909991537876 ¦ OTC ¦ 154260\n42 tabl.\n05909991537883 ¦ OTC ¦ 154261\n98 tabl.",
"substance": "Hippocastani seminis extractum siccum 192,1 - 257,9 mg",
"common_name": "Hippocastani seminis extractum siccum",
"pl_product_id": "100484968",
"pozwolenie_nr": "28354",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about hippocastani semen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.